Recently, the IL-33/ST2L axis has been shown to be involved in the progression of cancer, either positively or negatively, depending on the cancer type, through modulating the tumor microenvironment, such as infiltration of T cells and inflammation. This evidence concerns the gene IL33 and neoplasm.